BCWORLD PHARM. Co. Ltd (200780) — Cash Flow Reinvestment Rate
BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow Reinvestment Rate of 1.95x as of September 2025, reinvesting ₩2.79 Billion (capex ₩1.63 Billion plus investments ₩-1.16 Billion) from operating cash flow of ₩1.43 Billion. See BCWORLD PHARM. Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BCWORLD PHARM. Co. Ltd Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for BCWORLD PHARM. Co. Ltd across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of BCWORLD PHARM. Co. Ltd.
Annual Cash Flow Reinvestment Rate for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year capital reinvestment analysis for BCWORLD PHARM. Co. Ltd. See financial flexibility index of BCWORLD PHARM. Co. Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.88x | ₩3.55 Billion | ₩4.04 Billion | ₩2.41 Billion | ▲ +48.2% |
| 2023 | 0.59x | ₩6.47 Billion | ₩10.94 Billion | ₩2.71 Billion | ▼ -42.5% |
| 2022 | 1.03x | ₩7.08 Billion | ₩6.88 Billion | ₩6.22 Billion | ▼ -42.8% |
| 2019 | 1.80x | ₩21.76 Billion | ₩12.11 Billion | ₩21.32 Billion | ▼ -69.1% |
| 2018 | 5.81x | ₩31.03 Billion | ₩5.34 Billion | ₩29.92 Billion | ▲ +176.2% |
| 2017 | 2.10x | ₩16.62 Billion | ₩7.90 Billion | ₩16.58 Billion | ▼ -96.0% |
| 2016 | 52.54x | ₩12.80 Billion | ₩243.66 Million | ₩12.56 Billion | ▲ +1726.7% |
| 2015 | 2.88x | ₩25.26 Billion | ₩8.78 Billion | ₩25.26 Billion | — |